Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Coat color dilution in mice because of inactivation of the melanoma antigen MART-1.

Aydin IT, Hummler E, Smit NP, Beermann F.

Pigment Cell Melanoma Res. 2012 Jan;25(1):37-46. doi: 10.1111/j.1755-148X.2011.00910.x. Epub 2011 Oct 7.

PMID:
21943097
2.

MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes.

Hoashi T, Watabe H, Muller J, Yamaguchi Y, Vieira WD, Hearing VJ.

J Biol Chem. 2005 Apr 8;280(14):14006-16. Epub 2005 Jan 28.

3.

Inactivation of Pmel alters melanosome shape but has only a subtle effect on visible pigmentation.

Hellström AR, Watt B, Fard SS, Tenza D, Mannström P, Narfström K, Ekesten B, Ito S, Wakamatsu K, Larsson J, Ulfendahl M, Kullander K, Raposo G, Kerje S, Hallböök F, Marks MS, Andersson L.

PLoS Genet. 2011 Sep;7(9):e1002285. doi: 10.1371/journal.pgen.1002285. Epub 2011 Sep 15.

4.

The ocular albinism type 1 (OA1) G-protein-coupled receptor functions with MART-1 at early stages of melanogenesis to control melanosome identity and composition.

Giordano F, Bonetti C, Surace EM, Marigo V, Raposo G.

Hum Mol Genet. 2009 Dec 1;18(23):4530-45. doi: 10.1093/hmg/ddp415. Epub 2009 Aug 28.

PMID:
19717472
5.

Melanosomal pH controls rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells.

Ancans J, Tobin DJ, Hoogduijn MJ, Smit NP, Wakamatsu K, Thody AJ.

Exp Cell Res. 2001 Aug 1;268(1):26-35.

PMID:
11461115
6.

Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice.

Shimshek DR, Jacobson LH, Kolly C, Zamurovic N, Balavenkatraman KK, Morawiec L, Kreutzer R, Schelle J, Jucker M, Bertschi B, Theil D, Heier A, Bigot K, Beltz K, Machauer R, Brzak I, Perrot L, Neumann U.

Sci Rep. 2016 Feb 25;6:21917. doi: 10.1038/srep21917.

7.

Multidrug resistance decreases with mutations of melanosomal regulatory genes.

Xie T, Nguyen T, Hupe M, Wei ML.

Cancer Res. 2009 Feb 1;69(3):992-9. doi: 10.1158/0008-5472.CAN-08-0506. Epub 2009 Jan 20.

8.

The silver locus product (Silv/gp100/Pmel17) as a new tool for the analysis of melanosome transfer in human melanocyte-keratinocyte co-culture.

Singh SK, Nizard C, Kurfurst R, Bonte F, Schnebert S, Tobin DJ.

Exp Dermatol. 2008 May;17(5):418-26. doi: 10.1111/j.1600-0625.2008.00702.x. Epub 2008 Mar 6.

PMID:
18331332
9.

Autoimmune etiology of generalized vitiligo.

Le Poole IC, Luiten RM.

Curr Dir Autoimmun. 2008;10:227-43. doi: 10.1159/000131485. Review.

PMID:
18460889
10.

Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein.

Hoashi T, Sato S, Yamaguchi Y, Passeron T, Tamaki K, Hearing VJ.

FASEB J. 2010 May;24(5):1616-29. doi: 10.1096/fj.09-151019. Epub 2010 Jan 7.

11.

The melanosomal protein PMEL17 as a target for antibody drug conjugate therapy in melanoma.

Chen Y, Chalouni C, Tan C, Clark R, Venook R, Ohri R, Raab H, Firestein R, Mallet W, Polakis P.

J Biol Chem. 2012 Jul 13;287(29):24082-91. doi: 10.1074/jbc.M112.361485. Epub 2012 May 21.

12.

A mart-1::Cre transgenic line induces recombination in melanocytes and retinal pigment epithelium.

Aydin IT, Beermann F.

Genesis. 2011 May;49(5):403-9. doi: 10.1002/dvg.20725.

PMID:
21309074
13.

Manassantin B inhibits melanosome transport in melanocytes by disrupting the melanophilin-myosin Va interaction.

Chang H, Choi H, Joo KM, Kim D, Lee TR.

Pigment Cell Melanoma Res. 2012 Nov;25(6):765-72. doi: 10.1111/pcmr.12002. Epub 2012 Oct 5.

PMID:
22863119
14.

Maintenance of immune hyporesponsiveness to melanosomal proteins by DHICA-mediated antioxidation: Possible implications for autoimmune vitiligo.

Liu XM, Zhou Q, Xu SZ, Wakamatsu K, Lei TC.

Free Radic Biol Med. 2011 May 1;50(9):1177-85. doi: 10.1016/j.freeradbiomed.2011.01.017. Epub 2011 Jan 21.

PMID:
21256957
15.

How are proliferation and differentiation of melanocytes regulated?

Hirobe T.

Pigment Cell Melanoma Res. 2011 Jun;24(3):462-78. doi: 10.1111/j.1755-148X.2011.00845.x. Epub 2011 Mar 29. Review.

PMID:
21375698
16.

The Silver locus product Pmel17/gp100/Silv/ME20: controversial in name and in function.

Theos AC, Truschel ST, Raposo G, Marks MS.

Pigment Cell Res. 2005 Oct;18(5):322-36. Review.

17.

Myosin V associates with melanosomes in mouse melanocytes: evidence that myosin V is an organelle motor.

Wu X, Bowers B, Wei Q, Kocher B, Hammer JA 3rd.

J Cell Sci. 1997 Apr;110 ( Pt 7):847-59.

18.

Transforming growth factor beta1 mediates hypopigmentation of B16 mouse melanoma cells by inhibition of melanin formation and melanosome maturation.

Martínez-Esparza M, Ferrer C, Castells MT, García-Borrón JC, Zuasti A.

Int J Biochem Cell Biol. 2001 Oct;33(10):971-83.

PMID:
11470231
19.

Melanosomal proteins as melanoma-specific immune targets.

Sakai C, Kawakami Y, Law LW, Furumura M, Hearing VJ Jr.

Melanoma Res. 1997 Apr;7(2):83-95. Review.

PMID:
9167173

Supplemental Content

Support Center